1, 35, 2, 06, 35 prövningar och 6769 patienter) observerades hos patienter som behandlades med rekombinant humant erytropoietin. ###>1.35, 2.06, 35 trials and 6769 patients) was observed in patients treated with recombinant human erythropoietin.